Probiotics for Depression in Cancer Patients

NARecruitingINTERVENTIONAL
Enrollment

270

Participants

Timeline

Start Date

November 15, 2023

Primary Completion Date

December 15, 2024

Study Completion Date

March 15, 2025

Conditions
DepressionAnxiety DisorderProbioticsGastrointestinal CancerQuality of LifeChemotherapy
Interventions
DIETARY_SUPPLEMENT

Psychobiotics

Dietary Supplement: A four probiotic regime, containing Lactobacillus rhamnosus, Bifidobacterium animalis subsp. lactis, Bifidobacterium breve, and Bifidobacterium longum at a concentration of 1, 000,000,000 CFU.

OTHER

Placebo

The placebo regime, containing powdered glucose polymer, will be identical in packaging, appearance, consistency, and solubility in drinking water, thus making it impossible to recognize which are placebo and which the therapeutic formulation. Both will be identically standardized by the same pharmaceutical company \[Uni-Pharma, Greece\].

Trial Locations (1)

54636

RECRUITING

AHEPA University Hospital, Thessaloniki

All Listed Sponsors
lead

Aristotle University Of Thessaloniki

OTHER

NCT06496438 - Probiotics for Depression in Cancer Patients | Biotech Hunter | Biotech Hunter